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Abstract
Rationale—Repeated methamphetamine (MA) use leads to increases in the incentive 
motivational properties of the drug as well as cognitive impairments. These behavioral alterations 
persist for some time following abstinence, and neuroadaptations in the structure and function of 
the prefrontal cortex (PFC) are particularly important for their expression. However, there is a 
weak understanding of the changes in neural firing and oscillatory activity in the PFC evoked by 
repeated drug use, thus complicating the development of novel treatment strategies for addiction.
Objectives—The purpose of the current study was to assess changes in cognitive and brain 
function following MA sensitization.
Methods—Sensitization was induced in rats, then temporal and recognition memory were 
assessed after 1 or 30 days of abstinence. Electrophysiological recordings from the medial PFC 
were also acquired from rats whereupon simultaneous measures of oscillatory and spiking activity 
were examined.
Results—Impaired temporal memory was observed after 1 and 30 days of abstinence. However, 
recognition memory was only impaired after 1 day of abstinence. An injection of MA profoundly 
decreased neuronal firing rate and the anesthesia-induced slow oscillation (SO) in both sensitized 
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(SENS) and control (CTRL) rats. Strong correlations were observed between the SO and gamma 
band power, which was altered in SENS animals. A decrease in the number of neurons phase-
locked to the gamma oscillation was also observed in SENS animals.
Conclusions—The changes observed in PFC function may play an integral role in the 
expression of the altered behavioral phenotype evoked by MA sensitization.
Keywords
Methamphetamine; Cognition; Abstinence; Prefrontal cortex; In vivo electrophysiology; Gamma 
oscillation; Slow oscillation; Local field potential; Single unit; Phase locking
Introduction
Repeated methamphetamine (MA) use is associated with progressive increases in drug 
craving and seeking behavior (Tolliver et al. 2010). MA abusers also exhibit impairments in 
a range of cognitive functions including decision-making (Paulus et al. 2003), attention 
(Salo et al. 2009), and episodic memory (Simon et al. 2004). Following abstinence, 
enhanced craving and seeking are observed in parallel with impairments in executive 
function, which may persist for over a year (Salo et al. 2011; Sax and Strakowski 2001). 
However, performance on other forms of cognitive function including episodic memory, 
may improve after ~6 months of abstinence (Simon et al. 2004). Given the well-defined role 
of the prefrontal cortex (PFC) in drug craving (George and Koob 2010) and advanced forms 
of cognitive function (Euston et al. 2012), impairments in neural processing in the PFC may 
be among the most enduring and debilitating features of repeated MA use.
Similar to MA users, MA-sensitized rodents exhibit craving and seeking behaviors in 
parallel with cognitive abnormalities during abstinence (Dalley et al. 2005). Sensitized 
behavioral responses to drugs are thought to be associated with increases in the attribution of 
incentive salience to drug-paired stimuli that are likely mediated by changes in structure and 
function of neural circuits necessary to encode reward-related information (Steketee and 
Kalivas 2011).
Deficits in cognitive flexibility (Kosheleff et al. 2012; Simon et al. 2000), in addition to 
temporal and episodic memory (Cheng et al. 2007; Wittmann et al. 2007; Belcher et al. 
2006; Simon et al. 2004) are observed in both humans and animals following repeated MA, 
which may play a role in the inability to abstain from drug taking. It has been argued that 
deficits in episodic or temporal memory may increase the difficulty for an addicted 
individual to follow a treatment plan and apply it in the future (Pitel et al. 2007; Bechara 
2005). Impairments in time perception are also observed in MA abusers (Williamson et al. 
2008), which could contribute to their propensity for impulsive decision-making and 
increase the probability of relapse (Kurti et al. 2013; Hoffman et al. 2006). Furthermore, 
MA abusers have impairments in episodic memory during initiation, retrieval, and execution 
of previously experienced and encoded memories (Iudicello et al. 2011).
Temporal and episodic memory are commonly measured in rodents using temporal order 
recognition memory (TORM) and novel object recognition (NOR) tasks, respectively. 
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TORM examines an organism’s ability to sequence events in time and is disrupted by 
transient inactivation of the PFC (Hannesson et al. 2004). However, no studies to date have 
examined the effects of repeated MA on this behavior. Recognition memory is impaired 
following transient inactivation of the hippocampus (HC) (Broadbent et al. 2010) and the 
perirhinal cortex (Hannesson et al. 2004), specifically during memory encoding, retrieval, 
and consolidation (Winters and Bussey 2005). Furthermore, rodents receiving repeated MA 
exhibit impairments in NOR (Belcher et al. 2006; Camarasa et al. 2010; Herring et al. 2008; 
Lu et al. 2010; Mizoguchi et al. 2008; Reichel et al. 2010, 2012). As such, the goal of this 
study was to induce sensitization in rats, and then use TORM and NOR as indices of frontal 
and temporal lobe function to determine how repeated MA effects cognitive functions after 
short-term and extended abstinence.
Persistent changes in neural activity that last beyond the acute pharmacological effects of 
MA are likely critical for the expression of sensitization and the impaired cognitive 
phenotype observed following repeated MA use. For example, individuals using or recently 
abstinent from MA display increases in EEG power in delta and theta frequencies, which 
correlates with poor episodic memory and information processing compared with controls 
(Newton et al. 2004). Repeated psychostimulant administration has also been shown to 
change firing and oscillatory activity in the rodent PFC, which supports the hypothesis that 
altered neural processing in this structure may contribute to impaired cognitive function 
(Homayoun and Moghaddam 2006; Lapish et al. 2012).
Considerable evidence points to synchronous activity among neural oscillations and spiking 
as a mechanism for encoding information (Ward 2003). In reduced states of vigilance, such 
as sleep and anesthesia, transient states of synchronous activity are observed in a number of 
brain regions (Steriade 1997). During these states, a <1.5-Hz slow oscillation (SO) is 
commonly observed that is associated with intense bouts of synaptic activity resulting in 
bursts of action potentials and increased oscillatory power (Steriade et al. 1993). A number 
of physiological phenomena, from replay to increased gamma power, are observed during 
the SO (Steriade 2006). These phenomena are driven, in part, by increases in synaptic drive 
resulting in large positive deflections (upstates) of local field potentials (LFP) and likely 
play a critical role in plasticity and neural encoding (Masquelier et al. 2009). SOs remain 
intact following urethane anesthesia (Pirch et al. 1985), thus motivating its use in this study 
to examine how repeated MA use alters PFC firing and oscillatory activity evoked by the 
SO.
Gamma oscillations (30–100 Hz) are considered important for temporal encoding (Buzsaki 
and Chrobak 1995), storage and recall of information (Lisman and Idiart 1995), and are 
modulated by SOs (Isomura et al. 2006). Phase locking of spike activity to the gamma 
oscillation is hypothesized to play an important role in the formation of localized cell 
assemblies and information transfer between them (Sirota et al. 2008). Moreover, 
disturbances in gamma are observed in a number of neuropsychiatric disorders, including 
addiction (Liu et al. 2005) and schizophrenia (Williams and Boksa 2010), and these 
disturbances may represent an aspect of neural processing that is critically altered in these 
clinical populations. The current study provides the first examination of the persistent 
changes in neural firing and ongoing oscillatory activity evoked by repeated MA 
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administration, to better understand the changes in brain function brought about by drugs of 
abuse.
Materials and methods
Subjects
Seventy-one adult male (PND 64 at beginning of experiments) Sprague–Dawley rats 
(Harlan, Indianapolis, IN) weighing 250–300 g were individually housed and maintained on 
a reverse light/dark schedule with ad libitum access to food and water. All procedures were 
approved by the Purdue School of Science Institutional Animal Care and Use Committee 
and conformed to the Guidelines for the Care and Use of Mammals in Neuroscience and 
Behavioral Research (2003).
Drug treatments
Rats were administered either methamphetamine hydrochloride (MA; Sigma Chemical Co., 
St Louis, Mo., USA) or 0.9 % saline (SAL) via intraperitoneal (i.p.) injection. MA was 
dissolved in sterile SAL and injected at a dose of 0.5 or 5.0 mg/kg in a final volume of 1.0 
ml/kg. For surgeries, rats received an i.p. injection of urethane (Sigma Chemical Co., St 
Louis, Mo., USA) ~4 h before surgery at a dose of 1.5 g/kg dissolved in sterile water in a 
volume of 0.1 ml/kg. Rats were administered additional urethane if necessary at a dose of 
0.75 g/kg.
Behavioral measures
Behavioral sensitization—Animals were acclimated to the locomotor chamber (54.61-
cm diameter×41.91-cm height) for 60 min, then were injected, and placed back into the 
chamber for 60 min. Animals received 5.0 mg/kg of MA (SENS) or SAL (CTRL) every 
other day for 13 days (induction phase), and then were undisturbed for 7 days in their home 
cage. Following this period, rats were injected on Day 21 to provide an initial assessment of 
sensitization prior to cognitive testing. After all cognitive testing, SENS and CTRL groups 
were split into groups receiving one of two doses of MA (0.5 or 5.0 mg/kg) and SAL, 
counterbalanced over two consecutive days to confirm sensitization (MA challenge, days 
54–55). In each experiment, behavior was acquired via video camera mounted above the 
chambers, recorded in ANY-maze (Wood Dale, IL), and scored offline by two 
experimenters that were blind to animal treatment. Distance traveled (m) and stereotypy 
were the dependent variables used to assess sensitization. Cronbach’s alpha was used to 
assess the internal consistency of the 126 stereotypy values between the two raters. The 
scores between the two raters were highly reliable (α=0.82).
Cognitive testing—Rats were tested on TORM and NOR after 1 and 30 days of 
abstinence from repeated MA injections (Online Resource 1 Fig. S1 for timeline). For these 
experiments, an open field chamber (86.36×93.98×31.24 cm) was used that contained a strip 
of Velcro on two opposite sides of the chamber, approximately 16.5 cm from the corner of 
the box. The objects included two rubber ducks (8.1×6.35 cm), Rubik’s cubes (5.8×5.8 cm), 
or circular white cups (7.62×4.57 cm). The order that animals experienced the objects was 
randomized.
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On testing days, animals were placed in the chamber and were allowed to explore two 
identical objects for 4 min (trial 1). In trial 2, after a 60-min inter-trial interval, animals were 
placed in the chamber for 4 min with two identical objects different than the ones 
experienced previously. To assess temporal memory, rats were exposed to two objects (one 
from each previous trial) for another 4 min after a 45-min inter-trial interval (trial 3). NOR 
testing took place in the same chamber after a 45-min inter-trial interval. Animals in the 1- 
and 30-day abstinence groups were placed in the chamber with the most recent object (from 
trial 2) encountered along with a novel object for 4 min (trial 4). The amount of time 
(seconds) that an animal spent interacting with each object was the dependent variable.
Surgical procedures
Simultaneous spike train and LFP recordings were acquired from the PFC of anesthetized 
rats that went through an identical SENS procedure as described above. Following SAL or 
MA injection on day 21, one animal per day over 9 days underwent electrophysiological 
procedures. This period was chosen based on observations of TORM impairments in 
animals repeatedly treated with MA. Animals were anesthetized with urethane and placed 
into a Kopf stereotaxic frame for surgery. An incision was made, the skull was exposed, and 
a craniotomy was made over the PFC. After removal of the dura, a microelectrode array was 
lowered into the right medial PFC (AP, +2.70; ML, +0.50; DV, −1.5: relative to bregma).
To make the electrode arrays, 4×16 μm stablohm wires (California Fine Wire; Grover 
Beach, CA) were twisted into tetrodes and fed through 75 μm polyamide tubing (Small 
Parts, Logansport, IN). These were then fed through 34-gauge microfil tubing arrays (World 
Precision Instruments, Sarasota, FL). The array was fed through a 200-μl pipet tip, and 
tetrodes were wired to EIB-27 micro (Neuralynx; Bozeman, MT) and secured with dental 
acrylic.
LFP and single-unit recordings
Probes were lowered and cells were located before the start of recording (Online Resource 1 
Fig. S2 for timeline). At least one wire was referenced to a ground screw over the 
cerebellum (for LFPs) while the remaining wires were referenced locally (for single-unit 
recording). LFPs and spikes were acquired using a Neuralynx recording system. LFPs were 
sampled at 32,556 Hz then to 1017 Hz prior to analysis. After recordings, animals were 
euthanized using CO2 and brains were extracted to assess placements (Fig. 6). The shape 
and size of the probe are illustrated in the +3.20-mm section.
Data analysis
Locomotor activity was analyzed using repeated measures (RM) analysis of variance 
(ANOVA) with treatment as a between-subject factor and days as a within-subject factor. 
Stereotypy was scored using a 1–9 rating scale (Ellinwood and Balster 1974) and was 
analyzed using Kruskal–Wallis comparing day as a factor between and within treatments. 
Bonferroni and Dunn’s multiple comparisons were used for post-hoc testing locomotor and 
stereotypy, respectively. For the MA challenge data, stereotypy was examined via Mann–
Whitney to assess between-group differences. Time-series analysis using the first 25 min 
was conducted for locomotor activity and stereotypy on the final challenge day (5.0 mg/kg). 
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For locomotor activity, a two-way RM ANOVA was conducted with treatment as the 
between-subject factor and time as the within-subject factor. For stereotypy, a Friedman test 
for CTRL and SENS groups were performed separately with bin as the repeated measure. 
Mann–Whitney U tests (corrected to p<0.01) were conducted to compare between-group 
differences for each bin. Total time spent with each object for TORM and NOR were 
assessed via Bonferroni corrected planned comparisons within each experiment. Total 
exploration time for TORM and NOR was assessed using unpaired t tests to compare group 
differences between CTRL and SENS groups. Significance thresholds for planned 
comparisons (alpha) were adjusted for the number of comparisons and are stated in the 
results, whereas p values for Bonferroni post-hoc tests are reported as already corrected for 
number of comparisons by this statistic.
Spike trains were manually identified and sorted into individual cell clusters based on the 
features of the waveform in Spike Sort 3D (Neuralynx, Bozeman, MT). After cell sorting, 
duplicate timestamps and inter-spike intervals <3 ms were removed from spike trains. Only 
spike trains containing >150 spikes were analyzed.
All electrophysiological data were analyzed in MATLAB (MathWorks, Natick, MA). To 
detect the SO, LFPs were subsampled to 10 Hz to remove transient voltage deflections 
(Online Resource 1 Fig. S4). A SO was detected as an increase in voltage of >2000 μV 
lasting >200 ms. The duration was measured as the time voltage increased beyond 2000 μV 
until it dropped below 500 μV. The peak was determined as the maximum voltage in the 10-
Hz subsampled signal observed during a SO. The frequency was derived as the time 
between the beginning of two consecutive SOs.
To assess spike-LFP coupling, all spike trains from a recording session were binned at 1 ms 
resulting in a n×p spike train matrix where n=spike train number and p=time (1 ms bins). 
The spike train matrix was summed over time resulting in a 1×p vector, which was then 
convolved with a Gaussian kernel (1 ms step, 200 ms window). Synchrony between the 
spike train vector and the LFP was then assessed via magnitude squared coherence.
To assess chance levels of spike train-LFP synchrony, a Monte Carlo approach was 
employed. The ISIs of each spike train matrix were shuffled and then a spike train vector 
was created from the shuffled data as described above (Online Resource 1 Fig. S3). 
Synchrony between the LPF and the convolved vector constructed from shuffled spike trains 
was also assessed via magnitude-squared coherence as described above. This process was 
repeated (500 bootstraps) and for each bootstrap coherence was quantified by integrating the 
spectrum in the <1-Hz range. The resulting scalar values were then used to compute the 
mean and standard deviation of <1 Hz coherence in the shuffled data.
To assess coupling between slow and gamma oscillations, LFPs were digitally filtered with 
a first-order Chebyshev lowpass filter (<5 Hz) and a Chebyshev bandpass filter (30–50 Hz) 
to isolate the slow and gamma oscillation, respectively. To quantify the relationship between 
these oscillations, the analytic phase and amplitude of the gamma isolated signal was 
derived via Hilbert transform. From the analytic amplitude, the amplitude envelope of 
gamma was derived for the entire function and extracted for ±1.0 s surrounding the initiation 
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of the SO. Only recordings with clear up/down state transitions were analyzed in order to 
control for possible differences in synaptic activity induced by urethane anesthesia.
The relationship between the size of the SO and gamma power was determined by 
computing power in the 30–50-Hz band from the gamma-filtered signal during each SO. 
Gamma power was quantified by integrating the power in the 30–50-Hz range, which was 
computed via Thompsons multitaper method. Gamma power was then stratified by the 
corresponding size of the SO.
Phase locking to gamma was determined by extracting the phase of the gamma oscillation 
from the entire gamma-filtered time series. Then, the corresponding phase occurring with 
each spike was extracted and used to compute the probability density function (PDF) for 
each cell with phase increments of 20°. PDFs were then subjected to Rayleigh’s test of 
uniformity at alpha=0.01. All LFPs were acquired from different tetrodes than those used to 
acquire spike train data. For phase-locked cells, κ was estimated as the inverse of the sample 
variance. To determine the extent that cells would be phase-locked by chance, Monte Carlo 
analysis was performed on each spike train (500 bootstraps). The ISIs of each spike train 
were shuffled in time and then phase locking to an unshuffled LFP was assessed as 
described previously.
Results
Analysis of locomotor activity revealed progressive decreases over days in the SENS group 
(treatment×day interaction, F(7, 238)=3.18, p<0.005; Fig. 1a), which were paralleled by 
increases in stereotypy, depicted by a score of 6 or above on the rating scale indicating 
repetitive stereotypic movements (dashed line) (Fig. 1b; χ2=22.89, p<0.005). This inverse 
relationship likely reflects the transition from enhanced locomotor output to stereotypy.
Increased locomotor activity was observed on days 54–55 in both CTRL and SENS groups 
following the 0.5 mg/kg MA challenge (Fig. 1c, left, main effect of treatment, F(1, 42)= 
25.67, p<0.0001). Increased locomotor activity was observed only in the CTRL group 
following the 5.0 mg/kg dose (Fig. 1c, right, treatment x injection interaction F(1, 26)= 8.99, 
p<0.05). No differences in stereotypy between groups were observed following the 0.5 
mg/kg MA challenge (Fig. 1d, left). However, increased stereotypy was observed following 
the higher 5.0 mg/kg dose (SENS, U=2.00, p<0.005; CTRL, U=0.0, p<0.005; Fig. 1d, right). 
A significant increase in behavioral stereotypies were also observed between CTRL and 
SENS animals treated with MA (directional Mann–Whitney U=9.00, p<0.04)
For locomotor activity, time-series analyses on the challenge day (5.0 mg/kg) shows a main 
effect of time (F(4, 96)= 6.68, p<0.0001), treatment (F(3, 24)=18.95, p<0.0001), and a time 
by treatment interaction (F(12, 96)=7.38, p<0.0001) (Fig. 1e). Bonferroni post-hocs revealed 
a significant difference in locomotor activity between CTRL animals that received MA vs. 
SENS animals that received MA 15-min (p<0.001) and 20-min (p<0.002) post-injection. For 
stereotypy, we observed a significant difference between bins in the SENS group 
(χ2(4)=24.89, p<0.0001) and in the CTRL group (χ2(4)=16.93, p=0.0020; Fig. 1f). Mann–
Whitney U tests found significant differences between CTRL and SENS animals that 
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received MA 15-min (U=1.5, p=0.0037) and 20-min (U=2.5, p=0.0057) post-injection. 
Collectively, these data support that there is an augmented psychomotor response, indicative 
of behavioral sensitization, brought about by repeated injections of MA that persisted 41–42 
days following induction.
After 1 day of abstinence, neither TORM (Fig. 2(a1)) nor NOR (Fig. 2(a2)) was observed in 
the SENS animals. The CTRL group exhibited both TORM (t(7)=2.67, p<0.02; Fig. 2(a1)) 
and NOR (t(8)=3.02, p<0.01; Fig. 2(a2)) after this time point. After 30 days of abstinence, 
TORM (Fig. 2(b1)) was observed in the CTRL group (t(9)=4.19, p<0.005) but remained 
impaired in SENS animals. In contrast to TORM, no deficit in NOR (Fig. 2(b2)) was 
observed after 30 days of abstinence in SENS (t(9)=3.73, p<0.005) or CTRL animals 
(t(8)=2.72, p<0.02). Bonferroni planned comparisons were corrected to an alpha level of 
p<0.025. There were no differences after 1 or 30 days of abstinence between groups in total 
interaction time for TORM or NOR.
Twenty LFPs and 74 neurons were recorded from CTRL (n=7), and 14 LFPs and 65 neurons 
were recorded from SENS (n=6) animals (see Fig. 6 for placements). Spiking activity (top) 
and concomitant LFP activity (bottom) from a single animal throughout recording are 
illustrated in Fig. 3a. Power spectrum analysis of LFPs in CTRL and SENS animals prior to 
and following MA treatment found main effects of background (F(1, 3520)=4.92, 
p=0.0266), treatment (F(1, 3520)=46.29, p<0.001), and frequency (F(54, 3520)= 130.57, 
p<0.001). Decreases in power in both CTRL and SENS animals were observed following 
MA injection (Fig. 3b). Black lines above each power spectrum denote where 95 % 
confidence intervals for each frequency diverge.
No baseline differences in frequency of SOs (Fig. 3c) or firing rate (FR) (Fig. 3d) were 
observed between CTRL and SENS groups. No differences in the frequency of SOs (Fig. 
3c) during baseline or following SAL injection were observed across CTRL and SENS 
groups. However, an injection of 5.0 mg/kg of MA decreased the frequency of the SO 
(mixed design factorial ANOVA, main effect of treatment, F(2, 72)= 12.34, p<0.0001) and 
FR in both groups (mixed design factorial ANOVA, main effect of treatment, F(1, 
5472)=70.97, p<0.0001) when compared with baseline. The mean FR (1/mean ISI) of 
neurons ranged from 0.003 to 1.5 Hz (CTRL) and 0.003 to 1.3 Hz (SENS). The majority of 
spike trains recorded during baseline exhibited irregular firing properties as indicated by 
median values of >1.0 for both coefficient of variation (Dayan and Abbott 2001); 
CTRL=1.292, MA= 1.295) and Local Variation (Shinomoto et al. 2003); CTRL= 1.282, 
SENS=1.237) (Online Resource 1 Table S1). Median values of burst fraction assessed 
during baseline (Van Elburg and Van Ooyen 2004) were comparable for CTRL=0.162 and 
SENS=0.193 animals. Additionally, approximately half of the spike trains in both CTRL (50 
%) and SENS (55 %) met the criteria used in Parsegian et al. (2011) for burst neurons during 
baseline (see Online Resource 1 Table S1).
In order to assess changes in PFC function that might have contributed to the observed 
impairments in cognition (Fig. 2(a1 and a2)), and not those associated with the acute effects 
of MA administration, all subsequent analyses were performed during the baseline period 
prior to MA injection. During SOs (Fig. 4a, black), large increases in gamma oscillations 
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(Fig. 4a, green) were observed, which are highlighted in a zoomed in representation 
(bottom) showing that the gamma burst occurred during the up-state of the SO. The power 
in the gamma band was not distributed equally throughout the SO. Rather, a large spike in 
gamma power was observed during the rise of the SO (Fig. 4b; CTRL (left): goodness of fit, 
χ2(2034)=8.41×108, p<0.0001; SENS (right): χ2(2034)=5.01×108, p<0.0001). However, 
when the power of the gamma oscillation was stratified by the size of the corresponding SO, 
a clear positive relationship was observed where increases in the size of the SO 
corresponded to increases in gamma power (Fig. 4c, mixed design factorial ANOVA, main 
effect of SO size, F(1, 1358)=519.84, p<0.0001). Furthermore, the SENS group had less 
gamma power for relatively small SOs, while increases in gamma power were observed for 
larger SOs (treatment×size of SO interaction, F(1, 1358)=36.68, p<0.0001).
Figure 5a shows a representative SO (top) and the same SO filtered in the gamma band 
(bottom) with the vertical black lines in each panel denoting an action potential. In Fig. 5b, a 
large proportion of spiking activity during the recording period was phase-locked to the 
gamma oscillations. In CTRL animals (white bar), 54 % of all cells were phase-locked to the 
gamma oscillation, which is consistent with previous observations (Senior et al. 2008; van 
Wingerden et al. 2010). However, a smaller proportion of cells (31 %) were phase-locked in 
the SENS group (gray bar; Fisher’s exact test, χ2(1, N=139)=12.35, p<0.001). The degree of 
phase locking to gamma oscillations was greater than chance levels in both groups (dashed 
lines) calculated via surrogate data. The inset shows a rose plot of a gamma phase-locked 
cell from a single animal during baseline recording. Lastly, Fig. 6 depicts the unilateral 
placement of probes relative to bregma, with examples of photomicrographs from one 
animal with a successful hit shown directly below.
Discussion
Low doses of MA are known to stimulate locomotor activity (Futamura et al. 2010; 
Zakharova et al. 2009), while moderate-to-high doses commonly evoke stereotypy, which 
has been demonstrated in rats using various doses ranging from 1.0 to 10.0 mg/kg (McGuire 
et al. 2011; Slamberova et al. 2011). In the current experiments, MA-induced 
hyperlocomotion progressively transitioned to behavioral stereotypy during the repeated 5.0 
mg/kg dose. These alterations were also demonstrated to be long lasting. Relatively low 
locomotor output in SENS animals following the induction phase was attributable to 
increased stereotypies, which are together indicative of behavioral sensitization (Pierce and 
Kalivas 1997). Although the CTRL group exhibited increased stereotypy scores when they 
received 5.0 mg/kg of MA compared with SAL, these scores were <6 on the rating scale, 
and, as such, stereotypies were not detectable. Furthermore, this score is similar to that of 
the SENS group that received MA on Day 1, which is indicative of an acute MA response. 
Collectively, these data confirm that animals that received repeated MA developed 
behavioral sensitization that persisted at least 42 days following the induction phase.
To our knowledge, this is the first study to demonstrate impairments in TORM as a 
consequence of repeated MA administration in non-MA-intoxicated rodents. Deficits in 
NOR observed in SENS animals following 1 day of abstinence might complicate the 
interpretation of the TORM impairments observed on this day. It is possible that the inability 
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of an animal to determine if it has seen an object precludes its ability to determine the order 
in which objects were observed. Thus, deficits in TORM may be attributable to an inability 
to detect novelty 1-day post induction. However, 30-day post-induction, NOR was intact 
while TORM was impaired, which establishes that deficits in TORM were likely not 
attributable to an inability to detect novelty at this time.
The observed results for NOR are consistent with previous studies that have examined this 
behavior following brief periods (7 days or fewer) of abstinence (Camarasa et al. 2010; 
Herring et al. 2008; Lu et al. 2010; Mizoguchi et al. 2008; Reichel et al. 2010, 2012). 
Furthermore, the only study to have evaluated NOR following 30 days or more of abstinence 
from repeated MA found that NOR is not impaired with protracted abstinence (Clark et al. 
2007), which is also consistent with the current results.
These differences in the duration of impairments in TORM and NOR following induction 
suggests some level of specificity in the neural systems that are altered following drug 
cessation. The PFC is critical for the expression for TORM in both rats (Hannesson et al. 
2004) and monkeys (Petrides 1991), which supports that PFC-mediated behaviors, and the 
underlying neural processes facilitating them, are altered following abstinence. In support of 
this view, other PFC-mediated cognitive functions, such as behavioral flexibility and 
impulsivity, are also impaired in preclinical rodent models of MA addiction following 
abstinence (Dalley et al. 2007; Parsegian et al. 2011). However, we cannot rule out that 
repeated MA altered TORM and NOR via changes in the acuity of sensory systems (i.e., 
smell, vision). Importantly, the duration of TORM impairments suggests that this behavioral 
measure of PFC function was impaired when electro-physiological testing was performed, 
thus allowing us to explore MA-induced alterations in this brain region at a time point where 
PFC-mediated behavioral deficits likely exist. However, without having performed 
electrophysiological recordings 30-days after induction when TORM was still impaired, it is 
not possible to conclude that MA-induced electrophysiological changes in the PFC last as 
long as the 30-day impairment seen in TORM.
Interestingly, gamma band activity is elevated in both rodents and humans during 
recognition memory tasks. In one such study, awake-behaving mice exhibited elevated theta 
and gamma power in the dorsal subiculum, an area that receives projections from the CA1 
of the HC. In the same study, increased coherence in gamma between dorsal subiculum and 
CA1 was observed when rodents were exploring the environment without exploring objects 
(Chang and Huerta 2012). In humans, gamma activity assessed via EEG is increased when a 
familiar object is presented. However, decreased gamma power and phase locking between 
electrode pairs occurs as the familiar object is repeatedly presented, supporting that gamma 
activity is important for memory encoding (Gruber and Müller 2005). Although not directly 
measured in these experiments, it is possible that animals receiving repeated MA have 
difficulty encoding the memory of the familiar object due to alterations in normal gamma 
band activity. Furthermore, the aforementioned studies do not assess oscillatory activity in 
the PFC. Future studies will be necessary to determine whether repeated MA alters gamma 
band power and phase synchrony in the HC as well as the PFC in animals performing 
TORM and NOR to causally link the changes in physiology and behavior.
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The current study, to our knowledge, is the first to examine electrophysiological activity in 
the medial PFC using simultaneous measures of LFP and spiking activity in rodents 
following repeated MA. Initially, this structure was thought to be analogous to the primate 
dorsolateral PFC based on inputs from the medial dorsal thalamus (Rose and Woolsey 
1947). However, modern views of this structure suggest homology with ventromedial PFC 
(Balleine and O’Doherty 2009) and anterior cingulate cortex (Seamans et al. 2008).
Extended access self-administration of MA was previously shown to persistently alter the 
baseline FR and burst properties of PFC neurons (Parsegian et al. 2011). Furthermore, a 
single MA injection evoked a robust decrease in neural firing, which is consistent with 
previous studies using high doses of psychostimulants in either anesthetized or awake-
behaving animals (Gulley and Stanis 2010; Homayoun and Moghaddam 2006; Jang et al. 
2007). In the current study, no differences in baseline firing following sensitization were 
observed, which may be attributable to less exposure to the drug or the non-contingent route 
of administration. Importantly, the data presented herein suggest that alterations in 
oscillatory activity may be an initial neuroadaptation that precedes changes in baseline 
firing.
During baseline, we observed increases in neural firing and large increases of gamma power 
in both groups during the SO, which reflects increases in synaptic activity during the upstate 
(Hoffman et al. 2007). When gamma power was stratified by the size of the SO, a clear 
positive relationship was observed, which demonstrates that gamma power scales with the 
size of the SO, and by extension, possibly the strength of synaptic inputs. The gamma 
oscillation plays an important role in information processing, including object recognition 
(Martinovic et al. 2007). It is generated by GABAergic inter-neurons that provide inhibition 
in cortical networks (Bartos et al. 2007; Buzsaki and Chrobak 1995; Sohal et al. 2009) and 
while evoked increases in gamma power might be thought to reduce neural firing, 
experimental data suggest a more complex relationship. Driving the gamma oscillation 
increases the slope of the function that relates the number of spikes evoked by progressively 
larger inputs (stimulated excitatory postsynaptic currents) and was ultimately shown to 
amplify signals (i.e., increase spiking) in neocortical circuits (Sohal et al. 2009). In the 
current study, the slope of the function relating gamma power to SO size was steeper in the 
SENS group compared with CTRL, which could also reflect amplified signals in these 
neural circuits. In the PFC especially, optimal signal to noise ratios are hypothesized to be 
important for the maintenance and selection of behavior (Durstewitz and Seamans 2008). 
This balance could be persistently compromised in SENS animals and thus contribute to the 
impairments in cognitive function observed. Moreover, it is possible that alterations in the 
relationship between gamma power and the size of synaptic inputs could also contribute to 
the increases in the incentive motivational properties attributed to drugs and drug-related 
stimuli following repeated exposure.
Phase locking of action potentials to oscillatory activity is hypothesized to be an important 
feature of neural networks engaged in encoding, maintenance, or transfer of information 
(Lee et al. 2005; O’Keefe and Recce 1993). Specifically, gamma band phase locking is 
thought to coordinate neuronal activity in local neural networks and facilitates processes 
such as replay and memory consolidation (Carr et al. 2012; Colgin 2011). It may also be 
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critical for spike-time-dependent plasticity by strengthening connections between neurons 
and facilitating the formation of cell assemblies to transiently encode information (van 
Wingerden et al. 2010). Alterations in gamma band power and synchrony may be a critical 
long-term physiological change in individuals with mental illnesses, including addictions 
(Rømer Thomsen et al. 2013). The current study supports this view, as a larger portion of 
spike activity was phase-locked to the gamma oscillation in CTRL compared with the SENS 
group. This suggests that alterations in gamma band phase locking may be a physiological 
adaptation that persists following repeated MA administration, which also may negatively 
impact cognitive function. However, considering that these recordings were not collected in 
animals performing the cognitive tasks, it is not possible to confirm that changes seen in 
electrophysiology cause the observed deficits in cognition. To directly test this hypothesis, 
additional studies in awake-behaving animals will be required.
The current study demonstrates that repeated MA administration causes impairments in 
temporal and recognition memory, although the impairments in recognition memory may 
improve after extended abstinence. These impairments may be paralleled by alterations in 
the integrating and synchronous properties of gamma band activity in the PFC. Collectively, 
these results suggest that repeated MA exposure evokes large scale alterations in the 
physiological processes that mediate gamma band activity and possibly inhibitory drive in 
cortical networks. Further elucidation of these processes will inform our understanding of 
how information processing is altered and how this contributes to alterations in behavior in 
addicted individuals.
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Fig. 1. 
Locomotor activity and stereotypy during the induction phase and MA challenge. (a) Mean 
locomotor activity immediately following injections for each day of the induction phase 
(SENS, n=20; CTRL, n=17). (Bonferroni correction, #p<0.05; ##p<0.005; ###p<0.0005—
significantly lower within-group locomotor activity compared with day 1 in SENS animals). 
(b) Mean stereotypy during the induction phase (SENS, n=9; CTRL, n=8). 
(Dunn’s, #p<0.05; ###p<0.0005—significantly greater within-group stereotypy compared 
with day 1 in SENS animals). (c) Locomotor activity on days 54 and 55 following the 0.5 
mg/kg MA dose (left; SENS, n=12; CTRL, n=9) and 5.0 mg/kg dose (right; SENS, n=8; 
CTRL, n=9). (Bonferroni correction: *p<0.05; **p<0.005; ***p<0.0005—significantly 
different than rats that received a SAL injection). (Bonferroni correction: ###p<0.0005—
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significantly different than rats that received a MA injection). (d) Stereotypy on days 54 and 
55 following treatment with 0.5 mg/kg MA (left; SENS, n=12; CTRL, n=9) and 5.0 mg/kg 
dose (right; SENS, n=8; CTRL, n=6); (Mann–Whitney, *p<0.05—significantly different 
than CTRL rats that received a MA injection); (Mann–Whitney, *p<0.005—significantly 
different than rats that received a SAL injection). (e) Locomotor activity post-injection on 
the 5.0 mg/kg challenge day (SENS, n=8; CTRL, n=6). (Bonferroni correction, *p<0.01; 
**p<0.001—significantly different than SENS animals that received a MA injection). (f) 
Stereotypy post-injection on the 5.0 mg/kg challenge day (SENS, n=8; CTRL, n=6). (Mann–
Whitney, *p<0.01). All data are depicted as mean±SEM
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Fig. 2. 
(a1) TORM and (a2) NOR 1 day following the last injection of the induction phase (TORM: 
SENS, n=9; CTRL, n=8; NOR: SENS, n= 10, CTRL, n=9), and after 30 days of abstinence 
(TORM (b1): SENS, n= 10; CTRL, n=10; NOR (b2): SENS, n=10; CTRL, n=9). 
(Bonferroni corrected planned comparison, *p<0.02; **p<0.01; ***p<0.005—significantly 
different than other object)
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Fig. 3. 
(a) Representative spike trains (top) and an LFP trace (bottom) from a single animal 
throughout an experiment. (b) The mean (solid line)±SEM (shaded portion) of log spectral 
power of LFPs recorded from CTRL (left) versus SENS (right) animals pre-and post-
injection. (c) Frequency of SO (d) and frequency of FR during the entire recording session; 
(Tukey’s post-hoc, **p<0.005—significantly different than both groups during baseline)
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Fig. 4. 
(a) SO and gamma oscillation coupling during baseline. Representative SOs and gamma 
oscillations in a single animal, with a zoomed in representation from 1446 to 1451 s below. 
(b) Color: gamma envelope power for all SOs present in the dataset from all animals sorted 
via most gamma power (top) to least (bottom). Black: the overall mean from all SOs. (c) The 
relationship between the size of the SO and gamma power. The inset shows the distribution 
of sizes of SO collapsed on treatment. (Mixed design factorial ANOVA, treatment×size of 
SO interaction, ***p<0.0001)
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Fig. 5. 
(a) A representative example of a SO (top) and the same example bandpass filtered in the 
gamma band (bottom) during baseline from a single animal. The vertical black lines 
represent spiking activity of a single cell, notice they align with the peaks of the gamma 
oscillation. (b) Percentage of gamma phase-locked cells in the CTRL (white bar) and SENS 
(gray bar) groups with dashed lines reflecting chance levels of phase locking from surrogate 
data. (Fisher’s exact test, **p<0.001—significantly different than SENS group). The inset 
shows a rose plot of a gamma phase-locked cell from a single animal during baseline 
recording
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Fig. 6. 
Three coronal sections (Paxinos and Watson 1997) from +3.20 to +2.20 mm depict the 
unilateral placement of probes (AP, +2.70; ML, + 0.50; DV, −1.5) relative to bregma, with 
photomicrographs of a successful placement from one animal shown directly below. Open 
circles represent placements for CTRL animals (n=7), and closed circles represent 
placements for SENS animals (n=6)
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